An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment

S Drożdżal, J Rosik, K Lechowicz, F Machaj… - Drug Resistance …, 2021 - Elsevier
The COVID-19 pandemic is one of the greatest threats to human health in the 21st century
with more than 257 million cases and over 5.17 million deaths reported worldwide (as of …

Molecular mechanisms of cell death in neurological diseases

D Moujalled, A Strasser, JR Liddell - Cell Death & Differentiation, 2021 - nature.com
Tightly orchestrated programmed cell death (PCD) signalling events occur during normal
neuronal development in a spatially and temporally restricted manner to establish the neural …

Statins: a repurposed drug to fight cancer

W Jiang, JW Hu, XR He, WL Jin, XY He - Journal of Experimental & …, 2021 - Springer
As competitive HMG-CoA reductase (HMGCR) inhibitors, statins not only reduce cholesterol
and improve cardiovascular risk, but also exhibit pleiotropic effects that are independent of …

[HTML][HTML] Mechanisms of temozolomide resistance in glioblastoma-a comprehensive review

N Singh, A Miner, L Hennis, S Mittal - Cancer drug resistance, 2021 - ncbi.nlm.nih.gov
Glioblastoma (GBM) is the most common primary malignant brain tumor in adults and has an
exceedingly low median overall survival of only 15 months. Current standard-of-care for …

Wnt and PI3K/Akt/mTOR survival pathways as therapeutic targets in glioblastoma

A Barzegar Behrooz, Z Talaie, F Jusheghani… - International journal of …, 2022 - mdpi.com
Glioblastoma (GBM) is a devastating type of brain tumor, and current therapeutic treatments,
including surgery, chemotherapy, and radiation, are palliative at best. The design of effective …

RSL3 Drives Ferroptosis through NF‐κB Pathway Activation and GPX4 Depletion in Glioblastoma

S Li, Y He, K Chen, J Sun, L Zhang… - … Medicine and Cellular …, 2021 - Wiley Online Library
Glioblastoma, the most aggressive form of malignant glioma, is very difficult to treat because
of its aggressively invasive nature and high recurrence rates. RAS‐selective lethal 3 (RSL3) …

Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance.

MS Tomar, A Kumar, C Srivastava… - Biochimica et Biophysica …, 2021 - Elsevier
Temozolomide (TMZ) is a first-choice alkylating agent inducted as a gold standard therapy
for glioblastoma multiforme (GBM) and astrocytoma. A majority of patients do not respond to …

Potential strategies overcoming the temozolomide resistance for glioblastoma

S Jiapaer, T Furuta, S Tanaka, T Kitabayashi… - Neurologia medico …, 2018 - jstage.jst.go.jp
Glioblastoma (GBM) is a highly malignant type of primary brain tumor with a high mortality
rate. Although the current standard therapy consists of surgery followed by radiation and …

[HTML][HTML] Autophagy and the Wnt signaling pathway: A focus on Wnt/β-catenin signaling

S Lorzadeh, L Kohan, S Ghavami, N Azarpira - Biochimica et Biophysica …, 2021 - Elsevier
Cellular homeostasis and adaptation to various environmental conditions are importantly
regulated by the sophisticated mechanism of autophagy and its crosstalk with Wnt signaling …

Dihydroartemisinin-induced unfolded protein response feedback attenuates ferroptosis via PERK/ATF4/HSPA5 pathway in glioma cells

Y Chen, Y Mi, X Zhang, Q Ma, Y Song, L Zhang… - Journal of Experimental …, 2019 - Springer
Background Dihydroartemisinin (DHA) has been shown to exert anticancer activity through
iron-dependent reactive oxygen species (ROS) generation, which is similar to ferroptosis, a …